Jesse Kigozi
The cost-effectiveness of adding an ultrasound corticosteroid and local anaesthetic injection to advice and education for hip osteoarthritis
Kigozi, Jesse; Oppong, Raymond; Paskins, Zoe; Bromley, Kieran; Lewis, Martyn; Hughes, Gemma; Hughes, Emily; Hennings, Susie; Cherrington, Andrea; Hall, Alison; Holden, Melanie A; Stevenson, Kay; Menon, Ajit; Roberts, Philip; Peat, George; Jinks, Clare; Foster, Nadine E; Mallen, Christian D; Roddy, Edward
Authors
Raymond Oppong
Zoe Paskins z.paskins@keele.ac.uk
Kieran Bromley k.bromley1@keele.ac.uk
Alyn Lewis a.m.lewis@keele.ac.uk
Gemma Hughes
Emily Hughes
Susie Hennings
Andrea Cherrington
Alison Hall
Melanie Holden m.holden@keele.ac.uk
Kay Stevenson
Ajit Menon
Philip Roberts
George Peat
Clare Jinks c.jinks@keele.ac.uk
Nadine E Foster
Christian Mallen c.d.mallen@keele.ac.uk
Edward Roddy e.roddy@keele.ac.uk
Abstract
Objectives. Evidence for the comparative cost-effectiveness of intra-articular corticosteroid injection in people with hip osteoarthritis (OA) remains unclear. This study investigated the cost-effectiveness of best current treatment (BCT) comprising advice and education plus a single ultrasound-guided intraarticular hip injection (USGI) of 40mg triamcinolone acetonide and 4ml 1% lidocaine hydrochloride (BCT+US-T) versus BCT alone.
Methods. A trial-based cost-utility analysis of BCT+US-T compared with BCT was undertaken over 6 months. Patient-level cost data were obtained, and effectiveness was measured in terms of qualityadjusted life years (QALYs), allowing the calculation of cost per QALY gained from a United Kingdom (UK) National Health Service (NHS) perspective.
Results. BCT+US-T was associated with lower mean NHS costs (BCT+US-T minus BCT: £-161.6, 95% CI: £-583.95 to £54.18) and small but significantly higher mean QALYs than BCT alone over 6 months (BCT+US-T minus BCT: 0.0487, 95% CI: 0.0091, 0.0886). In the base case, BCT+US-T was the most cost-effective and dominated BCT alone. Differences in total costs were driven by number of visits to NHS consultants, private physiotherapists, and chiropractors, and hip surgery, which were more common with BCT alone than BCT+US-T.
Conclusion. Intra-articular corticosteroid injection plus BCT (BCT+US-T) for patients with hip OA results in lower costs and better outcomes, and is highly cost-effective, compared with BCT alone.
Citation
Kigozi, J., Oppong, R., Paskins, Z., Bromley, K., Lewis, M., Hughes, G., …Roddy, E. (2023). The cost-effectiveness of adding an ultrasound corticosteroid and local anaesthetic injection to advice and education for hip osteoarthritis. Rheumatology, https://doi.org/10.1093/rheumatology/kead659
Journal Article Type | Article |
---|---|
Acceptance Date | Nov 19, 2023 |
Online Publication Date | Dec 12, 2023 |
Publication Date | Dec 12, 2023 |
Deposit Date | Nov 24, 2023 |
Journal | Rheumatology |
Print ISSN | 1462-0324 |
Publisher | Oxford University Press |
Peer Reviewed | Peer Reviewed |
DOI | https://doi.org/10.1093/rheumatology/kead659 |
Keywords | economic evaluation, cost-effectiveness, cost-utility, hip osteoarthritis, corticosteroid injection. |
You might also like
Assessing collaborative efforts of making care fit for each patient: A systematic review
(2023)
Journal Article
Downloadable Citations
About Keele Repository
Administrator e-mail: research.openaccess@keele.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2024
Advanced Search